Ueta K - Search Results

1

Glucotoxicity targets hepatic glucokinase in Zucker diabetic fatty rats, a model of type 2 diabetes associated with obesity.

Ueta K, O'Brien TP, McCoy GA, Kim K, Healey EC, Farmer TD, Donahue EP, Condren AB, Printz RL, Shiota M. Ueta K, et al. Am J Physiol Endocrinol Metab. 2014 Jun 1;306(11):E1225-38. doi: 10.1152/ajpendo.00507.2013. Epub 2014 Apr 8. Am J Physiol Endocrinol Metab. 2014. PMID: 24714398 Free PMC article.

2

Correcting Postprandial Hyperglycemia in Zucker Diabetic Fatty Rats With an SGLT2 Inhibitor Restores Glucose Effectiveness in the Liver and Reduces Insulin Resistance in Skeletal Muscle.

O'Brien TP, Jenkins EC, Estes SK, Castaneda AV, Ueta K, Farmer TD, Puglisi AE, Swift LL, Printz RL, Shiota M. O'Brien TP, et al. Among authors: ueta k. Diabetes. 2017 May;66(5):1172-1184. doi: 10.2337/db16-1410. Epub 2017 Feb 28. Diabetes. 2017. PMID: 28246292 Free PMC article.

3

Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats.

Nawano M, Oku A, Ueta K, Umebayashi I, Ishirahara T, Arakawa K, Saito A, Anai M, Kikuchi M, Asano T. Nawano M, et al. Among authors: ueta k. Am J Physiol Endocrinol Metab. 2000 Mar;278(3):E535-43. doi: 10.1152/ajpendo.2000.278.3.E535. Am J Physiol Endocrinol Metab. 2000. PMID: 10710509 Free article.

4

Analysis of the effect of canagliflozin on renal glucose reabsorption and progression of hyperglycemia in zucker diabetic Fatty rats.

Kuriyama C, Xu JZ, Lee SP, Qi J, Kimata H, Kakimoto T, Nakayama K, Watanabe Y, Taniuchi N, Hikida K, Matsushita Y, Arakawa K, Saito A, Ueta K, Shiotani M. Kuriyama C, et al. Among authors: ueta k. J Pharmacol Exp Ther. 2014 Nov;351(2):423-31. doi: 10.1124/jpet.114.217992. Epub 2014 Sep 12. J Pharmacol Exp Ther. 2014. PMID: 25216746

5

The effect of combined treatment with canagliflozin and teneligliptin on glucose intolerance in Zucker diabetic fatty rats.

Oguma T, Kuriyama C, Nakayama K, Matsushita Y, Yoshida K, Kiuchi S, Ikenaga Y, Nakamaru Y, Hikida K, Saito A, Arakawa K, Oka K, Ueta K, Shiotani M. Oguma T, et al. Among authors: ueta k. J Pharmacol Sci. 2015 Apr;127(4):456-61. doi: 10.1016/j.jphs.2015.03.006. Epub 2015 Mar 28. J Pharmacol Sci. 2015. PMID: 25892328 Free article.

6

T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats.

Adachi T, Yasuda K, Okamoto Y, Shihara N, Oku A, Ueta K, Kitamura K, Saito A, Iwakura I, Yamada Y, Yano H, Seino Y, Tsuda K. Adachi T, et al. Among authors: ueta k. Metabolism. 2000 Aug;49(8):990-5. doi: 10.1053/meta.2000.7729. Metabolism. 2000. PMID: 10954015

7

Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models.

Liang Y, Arakawa K, Ueta K, Matsushita Y, Kuriyama C, Martin T, Du F, Liu Y, Xu J, Conway B, Conway J, Polidori D, Ways K, Demarest K. Liang Y, et al. Among authors: ueta k. PLoS One. 2012;7(2):e30555. doi: 10.1371/journal.pone.0030555. Epub 2012 Feb 15. PLoS One. 2012. PMID: 22355316 Free PMC article.

8

Inhibitory effect of hyperglycemia on insulin-induced Akt/protein kinase B activation in skeletal muscle.

Oku A, Nawano M, Ueta K, Fujita T, Umebayashi I, Arakawa K, Kano-Ishihara T, Saito A, Anai M, Funaki M, Kikuchi M, Oka Y, Asano T. Oku A, et al. Among authors: ueta k. Am J Physiol Endocrinol Metab. 2001 May;280(5):E816-24. doi: 10.1152/ajpendo.2001.280.5.E816. Am J Physiol Endocrinol Metab. 2001. PMID: 11287365 Free article.

9

Intestinal Sodium Glucose Cotransporter 1 Inhibition Enhances Glucagon-Like Peptide-1 Secretion in Normal and Diabetic Rodents.

Oguma T, Nakayama K, Kuriyama C, Matsushita Y, Yoshida K, Hikida K, Obokata N, Tsuda-Tsukimoto M, Saito A, Arakawa K, Ueta K, Shiotani M. Oguma T, et al. Among authors: ueta k. J Pharmacol Exp Ther. 2015 Sep;354(3):279-89. doi: 10.1124/jpet.115.225508. Epub 2015 Jun 23. J Pharmacol Exp Ther. 2015. PMID: 26105952

10

Beneficial effects of canagliflozin in combination with pioglitazone on insulin sensitivity in rodent models of obese type 2 diabetes.

Watanabe Y, Nakayama K, Taniuchi N, Horai Y, Kuriyama C, Ueta K, Arakawa K, Senbonmatsu T, Shiotani M. Watanabe Y, et al. Among authors: ueta k. PLoS One. 2015 Jan 23;10(1):e0116851. doi: 10.1371/journal.pone.0116851. eCollection 2015. PLoS One. 2015. PMID: 25615826 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters